Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: The DoubLNG pharmacokinetic study.
Cirrincione LR, Nakalema S, Chappell CA, Byakika-Kibwika P, Kyohairwe I, Winchester L, Mackline H, Pham MM, Cohn SE, Siccardi M, Owen A, Fletcher CV, Lamorde M, Scarsi KK. Cirrincione LR, et al. Among authors: lamorde m. Contraception. 2023 Jun;122:109975. doi: 10.1016/j.contraception.2023.109975. Epub 2023 Feb 12. Contraception. 2023. PMID: 36787829 Free PMC article. Clinical Trial.
Steady-state pharmacokinetic comparison of generic and branded formulations of stavudine, lamivudine and nevirapine in HIV-infected Ugandan adults.
Byakika-Kibwika P, Lamorde M, Kalemeera F, D'Avolio A, Mauro S, Di Perri G, Ryan M, Mayanja-Kizza H, Khoo S, Back D, Boffito M, Merry C. Byakika-Kibwika P, et al. Among authors: lamorde m. J Antimicrob Chemother. 2008 Nov;62(5):1113-7. doi: 10.1093/jac/dkn290. Epub 2008 Jul 18. J Antimicrob Chemother. 2008. PMID: 18641036 Free PMC article. Clinical Trial.
Nevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicin.
Lamorde M, Byakika-Kibwika P, Okaba-Kayom V, Ryan M, Coakley P, Boffito M, Namakula R, Kalemeera F, Colebunders R, Back D, Khoo S, Merry C. Lamorde M, et al. J Antimicrob Chemother. 2011 Jan;66(1):180-3. doi: 10.1093/jac/dkq411. Epub 2010 Nov 2. J Antimicrob Chemother. 2011. PMID: 21047828 Free PMC article. Clinical Trial.
Cardiac Conduction Safety during Coadministration of Artemether-Lumefantrine and Lopinavir/Ritonavir in HIV-Infected Ugandan Adults.
Byakika-Kibwika P, Lamorde M, Lwabi P, Nyakoojo WB, Okaba-Kayom V, Mayanja-Kizza H, Boffito M, Katabira E, Back D, Khoo S, Merry C. Byakika-Kibwika P, et al. Among authors: lamorde m. Chemother Res Pract. 2011;2011:393976. doi: 10.1155/2011/393976. Epub 2011 Apr 7. Chemother Res Pract. 2011. PMID: 22312553 Free PMC article.
Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults.
Byakika-Kibwika P, Lamorde M, Okaba-Kayom V, Mayanja-Kizza H, Katabira E, Hanpithakpong W, Pakker N, Dorlo TP, Tarning J, Lindegardh N, de Vries PJ, Back D, Khoo S, Merry C. Byakika-Kibwika P, et al. Among authors: lamorde m. J Antimicrob Chemother. 2012 May;67(5):1217-23. doi: 10.1093/jac/dkr596. Epub 2012 Feb 8. J Antimicrob Chemother. 2012. PMID: 22316571 Free PMC article. Clinical Trial.
191 results